FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

10637411000001100: Apo-Hydralazine 10mg tablets (Apotex Inc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36259801000001119 Apo-Hydralazine 10mg tablets (Apotex Inc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43181701000001111 Apo-Hydralazine 10mg tablets (Imported (United States)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Apo-Hydralazine 10mg tablets (Apotex Inc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Is a Product containing precisely hydralazine hydrochloride 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has active ingredient Hydralazine hydrochloride false Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has specific active ingredient Hydralazine hydrochloride true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Is pack of False Apo-Hydralazine 10mg tablets (Apotex Inc) Inferred relationship Existential restriction modifier
Apo-Hydralazine 10mg tablets (Apotex Inc) 100 tablet Has AMP True Apo-Hydralazine 10mg tablets (Apotex Inc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start